SCHEMBL2829691

SCHEMBL2829691

N[C@H](CCSCc1ccccc1)C(=O)O

nearest known ligand 0.82

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.61
ALPI P09923 1/20 0.55
PKM P14618 1/20 0.55
PTGS1 P23219 1/20 0.55
XIAP P98170 1/20 0.55
SLC7A5 Q01650 1/20 0.55
IDO1 P14902 1/20 0.51
BHMT Q93088 4/20 0.50
BHMT2 Q9H2M3 1/20 0.49
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KIF11 P52732 3/20 0.47
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
GRIK1 P39086 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2829688 1.00 CYP2C19 (0.61) CYP2C19ALPIPKMPTGS1XIAP
SCHEMBL341585 1.00 CYP2C19 (0.61) CYP2C19ALPIPKMPTGS1XIAP
Benzenemethanethiol SCHEMBL11583114 0.92 CYP2C19 (0.53) CYP2C19ALPIPKMPTGS1XIAP
SCHEMBL2453778 0.90 CYP2C19 (0.57) CYP2C19ALPIPKMPTGS1XIAP
SCHEMBL2452642 0.89 CYP2C19 (0.56) CYP2C19ALPIPKMPTGS1XIAP
SCHEMBL31425189 0.87 FOLH1 (0.51) CYP2C19BHMTBHMT2KIF11
SCHEMBL6051732 0.85 LMNA (0.49) PKMBHMTBHMT2ALDH1A1LMNA
SCHEMBL19800812 0.85 LMNA (0.49) PKMBHMTBHMT2ALDH1A1LMNA
SCHEMBL31060471 0.85 HPGD (0.49) CYP2C19BHMTBHMT2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL29199143 0.85 ALPI (0.53) CYP2C19ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9718921-B2 Amphiphilic derivatives of thioether containing block copolypeptides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-08-01 US claimed
US-20160002405-A1 AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES NATIONAL SCIENCE FOUNDATION 2016-01-07 US claimed
EP-2961758-A1 AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES The Regents of The University of California (US) 2016-01-06 EP claimed
US-20150057433-A1 PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-02-26 US claimed
EP-2831090-A1 PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS The Regents of The University of California (US) 2015-02-04 EP claimed
WO-2014134203-A9 AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-10-23 WO claimed
WO-2014134203-A1 AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-04 WO claimed
WO-2013148727-A1 PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-10-03 WO claimed
EP-1874790-B1 NEW S-ADENOSYL-L-METHIONINE ANALOGS WITH EXTENDED ACTIVATED GROUPS FOR TRANSFER BY METHYLTRANSFERASES RWTH AACHEN (DE) 2010-08-18 EP disclosed
EP-1712557-A1 New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases RWTH Aachen (DE) 2006-10-18 EP disclosed
EP-1123919-A1 PROCESS FOR PRODUCING PEPTIDYL ALDEHYDES Senju Pharmaceutical Co., Ltd. (JP) 2001-08-16 EP disclosed
US-4477441-A HYPOTENSIVE AGENTS MERCK & CO., INC. (US) 1984-10-16 US disclosed
US-4477440-A HYPERTENSIVE AGENTS; HYPERALDOSTERONISM; MEDICAL DIAGNOSIS; CYCLIC POLYPEPTIDES MERCK & CO., INC. (US) 1984-10-16 US disclosed
EP-0048159-A2 Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents UNIVERSITY OF MIAMI (US) 1982-03-24 EP disclosed
US-4153729-A ANTILIPEMIC AGENTS RECHERCHES PHARMACEUTIQUES ET SCIENTIFIQUES (FR) 1979-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057433-A1 PREPARATION OF FUNCTIONALIZED POLYPEPTIDES, PEPTIDES, AND PROTEINS BY ALKYLATION OF THIOETHER GROUPS PTMS, TMT1A, PTMA CYP2C19 2994/4885ALPI 4202/4885PKM 3705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.